New York, NY, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Facts and Factors have published a new research report titled “Seasonal Influenza Vaccine Market By Product Type (Quadrivalent, and Trivalent), By Sector (Public, and Private), End-User / Sales Channel (Hospitals, Government Suppliers, and Others): Global & Regional Industry Perspective, Comprehensive Analysis, Historical Trends, and Forecasts, 2021 – 2030”.
“According to the recent research report, the demand of global Seasonal Influenza Vaccine Market size & share expected to reach to USD 9,801.8 Million by 2030 from USD 5,638.3 Million in 2020, at a compound annual growth rate (CAGR) of 5.6% during the forecast period 2021 to 2030”
Global Seasonal Influenza Vaccine Market: Overview
Influenza (also terms as “flu”) is one of the serious diseases that can lead to hospitalization and even death. Influenza vaccines are widely used in order to protect an individual against infection by influenza viruses which are also known as flu shots or flu jabs. These vaccines act by developing antibodies that provide protection against circulating influenza virus infections.
Request Your Free Sample Report of Global Seasonal Influenza Vaccine Market @ https://www.fnfresearch.com/sample/seasonal-influenza-vaccine-market
(The free sample of this report is readily available on request).
Our Free Sample Report Includes:
- 2020 Updated Report Introduction, Overview, and In-depth industry analysis
- COVID-19 Pandemic Outbreak Impact Analysis Included
- 330+ Pages Research Report (Inclusion of Updated Research)
- Provide Chapter-wise guidance on Request
- 2020 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
- Includes Updated List of table & figures
- Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
- Facts and Factors research methodology
(Note: The sample of this report is updated with COVID-19 impact analysis before delivery)
Industry Major Market Players
- AstraZeneca
- Biodiem
- CSL Limited
- Emergent BioSolutions
- F. Hoffmann-La Roche Ltd
- Gamma Vaccines
- GlaxoSmithKline
- Merck
- Novartis
- Pfizer
- Sanofi
- Sinovac
- Hualan
- Abbott
- Mitsubishi Tanabe Pharma
- Serum Institute of India
- Mylan
To know an additional revised list of 2020-2021 top market players, request a sample report: https://www.fnfresearch.com/sample/seasonal-influenza-vaccine-market
Key questions answered in this report:
- What is the projected market size & growth rate of the Seasonal Influenza Vaccine Market?
- What are the key driving factors for the growth of the Seasonal Influenza Vaccine Market?
- What are the top companies operative in Seasonal Influenza Vaccine Market?
- What segments are covered in Seasonal Influenza Vaccine Market?
- How can I get free sample report/company profiles of the Seasonal Influenza Vaccine Market?
Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/seasonal-influenza-vaccine-market
Market Dynamics
Several factors such as increasing incidences of influenza worldwide coupled with the recent COVID-19 outbreak have supported the industry growth. For instance, as per the various research, the risk of severe Covid-19 effects may reduce post vaccination against Influenza. Due to this fact, the demand for influenza vaccines has witnessed significant growth during the year 2020-2021. According to the Centers for Disease Control and Prevention (CDC) tracking of flu vaccine distribution, as of December 2020, in the 2020-2021 flu season, 189.4 million influenza vaccines have been distributed in the U.S., compared to 174 million in the 2019-2020 season. Such factors would, in turn, support the overall industry growth to a great extent. On the flip side, high development costs and side effects are expected to hamper the influenza vaccine market growth over the study period.
Request Customized Copy of Report @ https://www.fnfresearch.com/customization/seasonal-influenza-vaccine-market
(We customize your report according to your research need. Ask our sales team for report customization.)
Global Seasonal Influenza Vaccine Market: Report Scope
| Report Attribute | Details |
| Market Size 2020 Value | USD 5,638.3 Million |
| Market Forecast for 2030 | USD 9,801.8 Million |
| Expected CAGR Growth | CAGR 5.6% from 2021-2030 |
| Base Year | 2020 |
| Forecast Year | 2021-2030 |
| Top Market Players | Biodiem, AstraZeneca, Emergent BioSolutions, CSL Limited, Gamma Vaccines, F. Hoffmann-La Roche Ltd, Merck, Novartis, Pfizer, Sanofi, GlaxoSmithKline, and Others |
| Segments Covered | Product Type, Sector, End-User, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Pricing Options | Request customized purchase options to meet your research needs. Explore purchase options |
Global Seasonal Influenza Vaccine Market: Segmentations
In terms of types, the global Seasonal Influenza Vaccine market is divided into Quadrivalent and Trivalent vaccines. In 2020, the quadrivalent product category accounted for the highest revenue share. This vaccine type is designed to protect against four different flu viruses, including influenza-A and influenza-B. Factors such as high efficiency coupled with larger demand for these products to protect viruses will support the segment growth to a great extent.
Depending upon the sector, the worldwide market is categorized into public and private. The private sector is projected to grow with the fastest annual growth rate of over 6%. Whereas, the end-user chapter is broadly analyzed into Hospitals, Government Suppliers, and Others. During the year 2020, the hospital segment recorded more than USD 1.8 bn, expanding at 5% of CAGR during the study period.
Inquire more about this report before purchase @ https://www.fnfresearch.com/inquiry/seasonal-influenza-vaccine-market
(You may enquire a report quote OR available discount offers to our sales team before purchase.)
Global Seasonal Influenza Vaccine Market: Regional Analysis
On the basis of regional analysis, the Seasonal Influenza Vaccine market is classified into North America, Europe, Asia-Pacific, Russia & CIS, Middle East, And Africa, and Latin America. Globally, developed regions such as North America and Europe are capturing lion’s share. Whereas, Asia Pacific region is growing at the fastest growth rate during the study period. The market of seasonal influenza vaccines in the Japan, China, and India is anticipated to grow at a considerable CAGR owing to the large population base coupled with the growing awareness level.
Browse the full report “Seasonal Influenza Vaccine Market By Product Type (Quadrivalent, and Trivalent), By Sector (Public, and Private), End-User / Sales Channel (Hospitals, Government Suppliers, and Others): Global & Regional Industry Perspective, Comprehensive Analysis, Historical Trends, and Forecasts, 2021 – 2030” at https://www.fnfresearch.com/seasonal-influenza-vaccine-market
This report segments the global Seasonal Influenza Vaccine market as follows:
Global Seasonal Influenza Vaccine Market: By Product Type
- Quadrivalent
- Trivalent
Global Seasonal Influenza Vaccine Market: By Sector
- Public
- Private
Global Seasonal Influenza Vaccine Market: By End-User
- Hospitals
- Government Suppliers
- Others
Key Highlights of this Report:
- Statistically Validated Analysis of Historical, Current, and Projected Industry Trends with Authenticated Market Sizes Information and Data in terms of Value and Volume, wherever applicable
- Detailed List of Key Buyers and End-Users (Consumers) analyzed as per Regions and Applications
- Overview of Key Marketing Strategies and Key Sales Channels Adopted in the Market
- Market Attractiveness Analysis and Key Investment Opportunity Analysis in the Market going forward
- Direct and Indirect Factors that Impacted the Industry as well Projected Rationales expected to affect the industry going forward
- Historical and Projected Company / Vendor / OEM / Supplier Market Shares, Competitive Landscape, and Player Positioning Data
For media inquiry, mail to: sales@fnfresearch.com
About Facts & Factors (FnF Research):
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Follow Us LinkedIn: https://www.linkedin.com/company/fnfresearch
Follow Us Twitter: https://twitter.com/fnfresearch
Contact Us:
Facts & Factors
USA: +1-347-989-3985
Email: sales@fnfresearch.com
Web: https://www.fnfresearch.com
Blog: http://fnfnewsblog.com
